GNI Group (FRA:3G6) Valuation Rank

View and export this data going back to . Start your Free Trial

What is GNI Group Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

GNI Group Valuation Rank Related Terms

Thank you for viewing the detailed overview of GNI Group's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

GNI Group (FRA:3G6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GNI Group Ltd (FRA:3G6) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

2160:Japan

Address

Shinjuku Park Tower, 3-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-1030

Website

http://www.gnipharma.com

GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.